Home / People / Jean-Baptiste Thiénot
Jean-Baptiste Thiénot

Jean-Baptiste Thiénot

Counsel

CMS Francis Lefebvre Avocats
2 rue Ancelle
92522 Neuilly-sur-Seine
Cedex
France
Languages French, English, German

Jean-Baptiste Thiénot is Counsel in the IP/IT team of CMS Francis Lefebvre Avocats. He mainly advises on industrial property law, particularly patent law.

His activity covers litigation (infringement and nullity actions, employee invention issues) as well as advice and drafting of contracts (R&D contracts, assignment and licensing, audit of rights portfolio) in various industrial sectors, particularly in the life sciences, mechanical and electronic fields. He is frequently involved in cases relating to products subject to specific regulations (health products, cosmetics, spraying, etc.).

Jean-Baptiste has also developed a particular expertise in the protection of business secrets/know-how (litigation, implementation of internal protection policies) and the regulation of health products (medicines, medical devices, etc.). He advises manufacturers in the health sector on their innovative projects, particularly in relation to e-health (telemedicine) and the compliance of their practices ("anti-gift" and "transparency" laws). 

Jean-Baptiste Thiénot has been a lawyer since 2008. He joined CMS Francis Lefebvre Avocats in 2018 after practising with the law firms Simmons & Simmons (2008-2011), Allen & Overy (2011-2013) and Bird & Bird (2013-2018).

more less

Industry focus: Healthcare and Life sciences

Legal 500 EMEA 2019

Intellectual Property : Patents

Legal 500 EMEA 2020

Propriété Intellectuelle : Brevets

Legal 500 EMEA 2020

Education

  • Master II « droit de la propriété littéraire et artistique », Université Paris II–Assas dirigé par Pierre-Yves Gautier (2005)
  • CAPA (2008)
more less

Memberships

  • Member of LES, APRAM and AIPPI
  • Member of Carré des juristes de France Biotech
  • Member of Bar Hauts-de-Seine
more less

Publications

  •  “Propriété intellectuelle et opération de fusion acquisition : préférez une revue sur mesure » - La lettre des fusions acquisitions et du private equity - Option Finance (march 2020)
  • « Le renouveau des interdictions provisoires (preliminary injunctions) » – Bulletin rapide de droit des affaires (BRDA) (march 2020)
  • Recent changes in patent law” - LinkedIn (march 2020)
  • « les risques inhérents à l’exécution de mesures provisoires ; CJUE, 12 septembre 2019, C-688/17 » – lettre PI (december 2019)
  • « La brevetabilité des procédés de présentation d’information : à propos des méthodes d’affichage facilitant la recherche et la navigation - TGI Paris, 11 juillet 2019, n° 16/02073 » – lettre PI (december 2019)
  • « La fiscalité avantageuse des revenus des actifs de propriété industrielle » - La lettre des fusions acquisitions et du private equity - co-auteru -  Option Finance (october 2019)
  •  “The interpretation and application of the doctrine of equivalence - Actavis v Eli Lilly 2 years on” co-écrit avec Caitlin Heard et Thomas Hirse, The Patent Lawyer (october 2019)
  • « Cannabis : a legal guide” – co-écrit avec les autres bureaux CMS (june 2019)
  • « Loi PACTE : analyse des nouveautés en droits de la propriété industrielle » - La lettre des fusions acquisitions et du private equity (Option Finance) (mai 2019)
  • « L’inventeur, l’employeur et les autres » - Dalloz IP-IT (march 2019)
  • « Pas de certificat complémentaire de protection pour un dispositif médical incorporant un produit pharmaceutique » - Lettre PI (january 2019)
  • Dossier (20 pages) consacré à la nouvelle loi sur la protection du secret des affaires paru dans Droit et Patrimoine (december 2018)
  • Article « Are your licenses UPC-proof » paru dans The Patent Lawyer - (september 2018)
  • « le sort incertain du licencié dans les procédures collectives » - La lettre des fusions acquisitions et du private equity - Option Finance (october 2018)
  • « Protection du secret des affaires : les nouveautés » - La lettre des fusions acquisitions et du private equity - Option Finance (june 2018)
  • UPC et Brevet Unitaire : quelle stratégie pour les entreprises ?, co-auteur -  Journal des Sociétés (november 2017)
  • La directive sur le secret des affaires : quel impact en France et dans l’Union Européenne - Journal des Sociétés (november 2017)
  • Chapitre français de l’ouvrage « Trade secret protection – a global guide », co-auteur - Globe Law and Business sous la direction de Trevor Cook
  • Publications sur Internet : « Le Brexit remet-il en question le nouveau système européen des brevets », Marketing-professionnel.fr ; « Enfin une vraie protection du secret des affaires pour les entreprises », latribune.fr
more less

Feed

Show only
28/07/2020
Leg­al 500 Par­is 2020: our law firm’s rank­ings
The 2020 edi­tion of the Leg­al 500 Par­is guide is avail­able. We thank our cli­ents for their trust and sup­port!This year, our firm is ranked in 20 ex­pert­ise, in­clud­ing: 4 in Tier 1: Tax; Em­ploy­ment; Se­cur­it­isa­tion...
12 November 2018
Are your li­censes UPC-proof?
Await­ing the de­cision of the Ger­man Fed­er­al Con­sti­tu­tion­al Court, we are only one step away from the entry in­to force of the Uni­fied Pat­ent Court (UPC) and the European Pat­ent with Unit­ary Ef­fect (Unit­ary...
09/07/2020
On the con­di­tions for im­ple­ment­ing the derog­a­tions to the French "anti-gift"...
On 17 June 2020, the de­cree im­ple­ment­ing French Or­din­ance No. 2017-49 of 19 Janu­ary 2017 on the be­ne­fits offered to health­care pro­fes­sion­als by man­u­fac­tur­ers or mar­keter of health products or ser­vices...
26/04/2019
Leg­al 500 EMEA 2020
The 2020 edi­tion of the Leg­al 500 EMEA guide is out. We would par­tic­u­larly like to thank our cli­ents for put­ting their trust in us! Our law firm’s rank­ings in France, Al­ger­ia and Mo­rocco France 4 in...
19/12/2019
WHAT ARE THE LEG­AL USES OF CAN­NABIS IN FRANCE?
Med­ic­al use of can­nabis In prin­ciple, the pro­duc­tion, man­u­fac­ture, trans­port, im­port, ex­port, hold­ing, of­fer, trans­fer, ac­quis­i­tion or use of can­nabis (plant and res­in) and THC are pro­hib­ited.Non­ethe­less...
31 August 2019
Con­sumer Products News­let­ter
Be­low you will find the top­ics of the news­let­ter:EUROPEAN UNI­ON ART­ICLESTrade Secret Law Re­form­sEuropean Court of Justice On Trade Mark Law: Is The Un­au­thor­ized Use Of A Qual­ity Test­ing La­bel For A Tooth­paste...
26/04/2019
Leg­al 500 EMEA 2019
The 2019 edi­tion of the Leg­al 500 EMEA guide is out. We would par­tic­u­larly like to thank our cli­ents for put­ting their trust in us! Our law firms’ rank­ings in France, Al­ger­ia and Mo­rocco France 5 in...
24/01/2019
The new trade secret pro­tec­tion in France
France has fi­nally ad­op­ted a spe­cif­ic le­gis­la­tion to pro­tect trade secrets (Law n°2018-670, Ju­ly 30th, 2018 and de­cree n° 2018-1126 dated Decem­ber 11th, 2018) im­ple­ment­ing EU Dir­ect­ive 2016/943. Even...
31/01/2019
The new trade secret pro­tec­tion in france
France has fi­nally ad­op­ted a spe­cif­ic le­gis­la­tion to pro­tect trade secrets (Law n°2018-670, Ju­ly 30th, 2018 and de­cree n° 2018-1126 dated Decem­ber 11th, 2018) im­ple­ment­ing EU Dir­ect­ive 2016/943. Even...
09 October 2018
Are your li­censes UPC-proof
Jean-Bap­tiste Thiénot from CMS Fran­cis Le­fe­b­vre Avocats fo­cuses on the con­trac­tu­al ar­range­ments that can be use­ful to get the most out of the UPC and Unit­ary Pat­ents.Await­ing the de­cision of the Ger­man...
05/09/2018
CMS ad­vises Bechtle on its ac­quis­i­tion of In­mac Wstore
CMS ad­vised Bechtle AG, one of the lead­ing in­de­pend­ent IT sys­tems in­teg­rat­ors, with around 8,600 em­ploy­ees and lis­ted on the TecDAX tech­no­logy in­dex, on its ac­quis­i­tion of In­mac Wstore, an IT busi­ness...
09 July 2018
Cham­pagne-Bio­mass
As part of fin­an­cing a pel­lets pro­duc­tion unit and a bio­mass-com­bined heat and power (CHP) plant in the town of Pomacle in the Cham­pagne-Ar­denne, CMS Fran­cis Le­fe­b­vre Avocats ad­vised the Me­ridiam in­vest­ment...